Charles Schwab’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$259K Sell
24,903
-4,400
-15% -$45.7K ﹤0.01% 3346
2025
Q1
$386K Buy
29,303
+2,500
+9% +$33K ﹤0.01% 3151
2024
Q4
$480K Buy
26,803
+7,755
+41% +$139K ﹤0.01% 3153
2024
Q3
$307K Hold
19,048
﹤0.01% 3278
2024
Q2
$514K Buy
19,048
+8,204
+76% +$222K ﹤0.01% 3187
2024
Q1
$211K Hold
10,844
﹤0.01% 3230
2023
Q4
$224K Hold
10,844
﹤0.01% 3262
2023
Q3
$345K Hold
10,844
﹤0.01% 3192
2023
Q2
$364K Buy
10,844
+8,851
+444% +$297K ﹤0.01% 3181
2023
Q1
$83.1K Hold
1,993
﹤0.01% 3277
2022
Q4
$67.6K Hold
1,993
﹤0.01% 3305
2022
Q3
$99K Hold
1,993
﹤0.01% 3224
2022
Q2
$79K Sell
1,993
-6,017
-75% -$239K ﹤0.01% 3310
2022
Q1
$296K Buy
8,010
+353
+5% +$13K ﹤0.01% 3215
2021
Q4
$749K Hold
7,657
﹤0.01% 3019
2021
Q3
$956K Buy
7,657
+218
+3% +$27.2K ﹤0.01% 2888
2021
Q2
$933K Buy
7,439
+1,471
+25% +$184K ﹤0.01% 2955
2021
Q1
$811K Sell
5,968
-457
-7% -$62.1K ﹤0.01% 2921
2020
Q4
$585K Buy
6,425
+240
+4% +$21.9K ﹤0.01% 2935
2020
Q3
$461K Buy
6,185
+824
+15% +$61.4K ﹤0.01% 2891
2020
Q2
$457K Buy
5,361
+4,872
+996% +$415K ﹤0.01% 2870
2020
Q1
$36K Hold
489
﹤0.01% 3172
2019
Q4
$35K Hold
489
﹤0.01% 3142
2019
Q3
$26K Sell
489
-162
-25% -$8.61K ﹤0.01% 3149
2019
Q2
$35K Sell
651
-2,359
-78% -$127K ﹤0.01% 3173
2019
Q1
$215K Buy
3,010
+1,887
+168% +$135K ﹤0.01% 3010
2018
Q4
$90K Sell
1,123
-137
-11% -$11K ﹤0.01% 3096
2018
Q3
$588K Buy
1,260
+137
+12% +$63.9K ﹤0.01% 2778
2018
Q2
$447K Buy
1,123
+303
+37% +$121K ﹤0.01% 2840
2018
Q1
$251K Hold
820
﹤0.01% 2931
2017
Q4
$242K Sell
820
-167
-17% -$49.3K ﹤0.01% 2939
2017
Q3
$541K Buy
987
+330
+50% +$181K ﹤0.01% 2692
2017
Q2
$392K Buy
+657
New +$392K ﹤0.01% 2767